Costa Rica vs Western Pacific (WHO region): Hypertension effective treatment coverage (controlled hypertension)
Costa Rica
49.7%
in 2019
Western Pacific (WHO region)
18.4%
in 2019
Costa Rica rank
4th
Western Pacific (WHO region) rank
6th
Hypertension effective treatment coverage (controlled hypertension) over time
- Costa Rica
- Western Pacific (WHO region)
How they compare
Costa Rica currently reports 49.7% against 18.4% in Western Pacific (WHO region), a difference of 31.3%.
That makes Costa Rica's figure about 2.7 times Western Pacific (WHO region)'s.
Across all 30 years both countries report, Costa Rica has been ahead every year.
Costa Rica ranks 4th and Western Pacific (WHO region) ranks 6th of 193 countries.
Costa Rica has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Costa Rica | Western Pacific (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 11.7% | 4.7% | 7.0% | Costa Rica |
| 2000s | 21.4% | 9.9% | 11.5% | Costa Rica |
| 2010s | 41.1% | 16.5% | 24.6% | Costa Rica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension effective treatment coverage (controlled hypertension), Costa Rica or Western Pacific (WHO region)?
- Costa Rica, at 49.7% against 18.4% in Western Pacific (WHO region) as of 2019.
- What is the difference in hypertension effective treatment coverage (controlled hypertension) between Costa Rica and Western Pacific (WHO region)?
- 31.3%, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and Western Pacific (WHO region)?
- 30 years are reported by both, from 1990 to 2019.
- How do Costa Rica and Western Pacific (WHO region) rank globally for hypertension effective treatment coverage (controlled hypertension)?
- Costa Rica ranks 4th and Western Pacific (WHO region) ranks 6th of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension effective treatment coverage (controlled hypertension )among adults aged 30-79, age-standardized (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.